Faculty Opinions recommendation of Pharmacologic properties, metabolism, and disposition of linaclotide, a novel therapeutic peptide approved for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation.

Author(s):  
Robin Spiller
Sign in / Sign up

Export Citation Format

Share Document